Literature DB >> 19902480

Toxicant-associated steatohepatitis in vinyl chloride workers.

Matt Cave1, Keith Cameron Falkner, Mukunda Ray, Swati Joshi-Barve, Guy Brock, Rehan Khan, Marjorie Bon Homme, Craig J McClain.   

Abstract

UNLABELLED: Although nonalcoholic steatohepatitis (NASH) is typically associated with obesity, it has also been reported to occur in lean individuals exposed to industrial chemicals. Occupational exposure to vinyl chloride (VC) is a well-documented risk factor for hemangiosarcoma, but has not previously been associated with steatohepatitis. Here we evaluate liver biopsies from 25 nonobese, highly exposed VC workers for steatohepatitis. Next, we evaluate associated metabolic and cytokine abnormalities in affected workers controlled by 26 chemical workers with no to minimal VC exposures, and 11 unexposed, healthy volunteers. Among highly exposed VC workers the prevalence of steatohepatitis was 80%. Of these, 55% had fibrosis and four had hemangiosarcoma. We have coined the term toxicant-associated steatohepatitis (TASH) to describe this condition, which was not explained by obesity or alcohol. Although mean serum transaminases were normal in TASH, total cytokeratin 18, but not the caspase-cleaved fragment, was elevated. Despite the absence of obesity, workers with TASH had insulin resistance with reduced adiponectin levels. TASH was also associated with markedly elevated serum tumor necrosis factor alpha and interleukins 1beta, 6, and 8. Serum antioxidant activity was reduced in TASH.
CONCLUSION: TASH occurred frequently in these nonobese VC workers with high cumulative exposures and normal liver enzymes. Elevated total cytokeratin 18 suggested the presence of necrotic cell death in TASH and may be a useful serologic biomarker. TASH was further characterized by insulin resistance, elevated proinflammatory cytokines, and impaired antioxidant defenses. The threshold VC exposure and the role of other chemical agents in TASH are as yet unknown.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19902480      PMCID: PMC4019991          DOI: 10.1002/hep.23321

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  36 in total

Review 1.  Follow-up report on the diagnosis of diabetes mellitus.

Authors:  Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

2.  Biochemical effects of vinyl chloride monomer on the liver of occupationally exposed workers.

Authors:  A A Saad; S M el-Sewedy; G A Bader; S M Mousa; M M Mahdy
Journal:  East Mediterr Health J       Date:  2000 Sep-Nov       Impact factor: 1.628

3.  Hepatic disease among workers at a vinyl chloride polymerization plant.

Authors:  H Falk; J L Creech; C W Heath; M N Johnson; M M Key
Journal:  JAMA       Date:  1974-10-07       Impact factor: 56.272

4.  Angiosarcoma of liver in the manufacture of polyvinyl chloride.

Authors:  J L Creech; M N Johnson
Journal:  J Occup Med       Date:  1974-03

5.  Liver function assessment in workers exposed to vinyl chloride.

Authors:  Marco Maroni; Anna Clara Fanetti
Journal:  Int Arch Occup Environ Health       Date:  2005-08-10       Impact factor: 3.015

6.  Clinical and histopathological features of NASH in workers exposed to chemicals with or without associated metabolic conditions.

Authors:  Helma P Cotrim; Luiz A R De Freitas; Carolina Freitas; Luciana Braga; Rodrigo Sousa; Fernando Carvalho; Raymundo Paraná; Rogerio Santos-Jesus; Zilton Andrade
Journal:  Liver Int       Date:  2004-04       Impact factor: 5.828

7.  Liver fibrosis in asymptomatic polyvinyl chloride workers.

Authors:  Tun-Jen Hsiao; Jung-Der Wang; Pei-Ming Yang; Pei-Cheng Yang; Tsun-Jen Cheng
Journal:  J Occup Environ Med       Date:  2004-09       Impact factor: 2.162

8.  Periportal fibrosis and other liver ultrasonography findings in vinyl chloride workers.

Authors:  M Maroni; F Mocci; S Visentin; G Preti; A C Fanetti
Journal:  Occup Environ Med       Date:  2003-01       Impact factor: 4.402

Review 9.  Vinyl chloride: still a cause for concern.

Authors:  J Kielhorn; C Melber; U Wahnschaffe; A Aitio; I Mangelsdorf
Journal:  Environ Health Perspect       Date:  2000-07       Impact factor: 9.031

10.  Increased risk of hepatocellular carcinoma and liver cirrhosis in vinyl chloride workers: synergistic effect of occupational exposure with alcohol intake.

Authors:  Giuseppe Mastrangelo; Ugo Fedeli; Emanuela Fadda; Flavio Valentini; Roberto Agnesi; Giancarlo Magarotto; Teresio Marchì; Andrea Buda; Massimo Pinzani; Diego Martines
Journal:  Environ Health Perspect       Date:  2004-08       Impact factor: 9.031

View more
  61 in total

Review 1.  Mechanisms of Environmental Contributions to Fatty Liver Disease.

Authors:  Banrida Wahlang; Jian Jin; Juliane I Beier; Josiah E Hardesty; Erica F Daly; Regina D Schnegelberger; K Cameron Falkner; Russell A Prough; Irina A Kirpich; Matthew C Cave
Journal:  Curr Environ Health Rep       Date:  2019-09

2.  Proteomic Analysis Reveals Novel Mechanisms by Which Polychlorinated Biphenyls Compromise the Liver Promoting Diet-Induced Steatohepatitis.

Authors:  Josiah E Hardesty; Banrida Wahlang; K Cameron Falkner; Hongxue Shi; Jian Jin; Yun Zhou; Daniel W Wilkey; Michael L Merchant; Corey T Watson; Wenke Feng; Andrew J Morris; Bernhard Hennig; Russell A Prough; Matthew C Cave
Journal:  J Proteome Res       Date:  2019-03-15       Impact factor: 4.466

Review 3.  Exposure to ambient air particulate matter and non-alcoholic fatty liver disease.

Authors:  Giovanni Tarantino; Domenico Capone; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-07-07       Impact factor: 5.742

4.  Liver Injury and Endotoxemia in Male and Female Alcohol-Dependent Individuals Admitted to an Alcohol Treatment Program.

Authors:  Irina A Kirpich; Craig J McClain; Vatsalya Vatsalya; Melanie Schwandt; Monte Phillips; Keith Cameron Falkner; Lucy Zhang; Catey Harwell; David T George; John C Umhau
Journal:  Alcohol Clin Exp Res       Date:  2017-03-02       Impact factor: 3.455

Review 5.  Role of xenobiotics in the induction and progression of fatty liver disease.

Authors:  James E Klaunig; Xilin Li; Zemin Wang
Journal:  Toxicol Res (Camb)       Date:  2018-05-18       Impact factor: 3.524

Review 6.  A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease.

Authors:  Zhi Zhong; John J Lemasters
Journal:  Alcohol Clin Exp Res       Date:  2018-09-17       Impact factor: 3.455

7.  Hepatic Injury Caused by the Environmental Toxicant Vinyl Chloride is Sex-Dependent in Mice.

Authors:  Banrida Wahlang; Josiah E Hardesty; Kimberly Z Head; Jian Jin; Keith C Falkner; Russell A Prough; Matthew C Cave; Juliane I Beier
Journal:  Toxicol Sci       Date:  2020-03-01       Impact factor: 4.849

8.  Triclosan leads to dysregulation of the metabolic regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease.

Authors:  Mei-Fei Yueh; Feng He; Chen Chen; Catherine Vu; Anupriya Tripathi; Rob Knight; Michael Karin; Shujuan Chen; Robert H Tukey
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

9.  Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice.

Authors:  Banrida Wahlang; K Cameron Falkner; Bonnie Gregory; Douglas Ansert; David Young; Daniel J Conklin; Aruni Bhatnagar; Craig J McClain; Matt Cave
Journal:  J Nutr Biochem       Date:  2013-04-22       Impact factor: 6.048

10.  Evaluation of Aroclor 1260 exposure in a mouse model of diet-induced obesity and non-alcoholic fatty liver disease.

Authors:  Banrida Wahlang; Ming Song; Juliane I Beier; K Cameron Falkner; Laila Al-Eryani; Heather B Clair; Russell A Prough; Tanasa S Osborne; David E Malarkey; J Christopher States; Matthew C Cave
Journal:  Toxicol Appl Pharmacol       Date:  2014-07-03       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.